Details for Patent: 9,782,402
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 9,782,402 protect, and when does it expire?
Patent 9,782,402 protects SUBLOCADE and is included in one NDA.
This patent has forty patent family members in twenty-nine countries.
Summary for Patent: 9,782,402
Title: | Injectable composition comprising buprenorphine |
Abstract: | The present invention is directed to a buprenorphine sustained release delivery system capable of delivering buprenorphine, a metabolite, or a prodrug thereof for a duration of about 14 days to about 3 months. The buprenorphine sustained release delivery system includes a flowable composition and a solid implant for the sustained release of buprenorphine, a metabolite, or a prodrug thereof. The implant is produced from the flowable composition. The buprenorphine sustained release delivery system provides in situ 1-month and 3-month release profiles characterized by an exceptionally high bioavailability and minimal risk of permanent tissue damage and typically no risk of muscle necrosis. |
Inventor(s): | Norton; Richard L. (Fort Collins, CO), Watkins; Andrew (Fort Collins, CO), Zhou; Mingxing (Fort Collins, CO) |
Assignee: | Indivior UK Limited (Berkshire, GB) |
Application Number: | 15/334,000 |
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Compound; |
Drugs Protected by US Patent 9,782,402
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Indivior Inc | SUBLOCADE | buprenorphine | SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS | 209819-001 | Nov 30, 2017 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | TREATING ADDICTION WITH 100 MG OR 300 MG DOSE OF BUPRENORPHINE | See Plans and Pricing | |||
Indivior Inc | SUBLOCADE | buprenorphine | SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS | 209819-001 | Nov 30, 2017 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | TREATING OPIOID ADDICTION BY ADMINISTERING BUPRENORPHINE | See Plans and Pricing | |||
Indivior Inc | SUBLOCADE | buprenorphine | SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS | 209819-001 | Nov 30, 2017 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | TREATING ADDICTION BY ONCE PER MONTH ADMINISTRATION OF BUPRENORPHINE | See Plans and Pricing | |||
Indivior Inc | SUBLOCADE | buprenorphine | SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS | 209819-001 | Nov 30, 2017 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | TREATING ADDICTION BY SUBCUTANEOUS INJECTION OF BUPRENORPHINE | See Plans and Pricing | |||
Indivior Inc | SUBLOCADE | buprenorphine | SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS | 209819-002 | Nov 30, 2017 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | TREATING ADDICTION BY ONCE PER MONTH ADMINISTRATION OF BUPRENORPHINE | See Plans and Pricing | |||
Indivior Inc | SUBLOCADE | buprenorphine | SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS | 209819-002 | Nov 30, 2017 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | TREATING ADDICTION BY SUBCUTANEOUS INJECTION OF BUPRENORPHINE | See Plans and Pricing | |||
Indivior Inc | SUBLOCADE | buprenorphine | SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS | 209819-002 | Nov 30, 2017 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | TREATING ADDICTION WITH 100 MG OR 300 MG DOSE OF BUPRENORPHINE | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,782,402
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2011263478 | See Plans and Pricing | |||
Brazil | 112012031290 | See Plans and Pricing | |||
Canada | 2801676 | See Plans and Pricing | |||
Chile | 2012003462 | See Plans and Pricing | |||
China | 103079544 | See Plans and Pricing | |||
Colombia | 6670529 | See Plans and Pricing | |||
Cyprus | 1120761 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |